THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Judith James to Antibodies, Monoclonal

This is a "connection" page, showing publications Judith James has written about Antibodies, Monoclonal.
Connection Strength

1.859
  1. Antigen nature and complexity influence human antibody light chain usage and specificity. Vaccine. 2016 05 27; 34(25):2813-20.
    View in: PubMed
    Score: 0.466
  2. Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis. Immunobiology. 2013 May; 218(5):745-54.
    View in: PubMed
    Score: 0.362
  3. Anti-U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA. J Mol Recognit. 2002 May-Jun; 15(3):163-70.
    View in: PubMed
    Score: 0.177
  4. Hydrogen-Deuterium Exchange Mass Spectrometry Reveals a Novel Binding Region of a Neutralizing Fully Human Monoclonal Antibody to Anthrax Protective Antigen. Toxins (Basel). 2022 01 25; 14(2).
    View in: PubMed
    Score: 0.173
  5. Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. J Autoimmun. 1999 Feb; 12(1):43-9.
    View in: PubMed
    Score: 0.141
  6. High Affinity Antibodies against Influenza Characterize the Plasmablast Response in SLE Patients After Vaccination. PLoS One. 2015; 10(5):e0125618.
    View in: PubMed
    Score: 0.109
  7. Implications of a vasodilatory human monoclonal autoantibody in postural hypotension. J Biol Chem. 2013 Oct 18; 288(42):30734-30741.
    View in: PubMed
    Score: 0.097
  8. Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization. Vaccine. 2012 Jun 13; 30(28):4276-83.
    View in: PubMed
    Score: 0.088
  9. And Yet It Moves: Oxidation of the Nuclear Autoantigen La/SS-B Is the Driving Force for Nucleo-Cytoplasmic Shuttling. Int J Mol Sci. 2021 Sep 08; 22(18).
    View in: PubMed
    Score: 0.042
  10. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.039
  11. Top-down Mass Spectrometry Analysis of Human Serum Autoantibody Antigen-Binding Fragments. Sci Rep. 2019 02 20; 9(1):2345.
    View in: PubMed
    Score: 0.035
  12. Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and MRL lpr/lpr antibodies. Clin Exp Immunol. 1994 Dec; 98(3):419-26.
    View in: PubMed
    Score: 0.026
  13. Immunodominance of antigenic site B over site A of hemagglutinin of recent H3N2 influenza viruses. PLoS One. 2012; 7(7):e41895.
    View in: PubMed
    Score: 0.022
  14. Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. J Clin Invest. 2011 Aug; 121(8):3109-19.
    View in: PubMed
    Score: 0.021
  15. Differential expression of immunomodulatory galectin-1 in peripheral leukocytes and adult tissues and its cytosolic organization in striated muscle. Glycobiology. 2010 May; 20(5):507-20.
    View in: PubMed
    Score: 0.019
  16. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies. Infect Immun. 2009 Jan; 77(1):162-9.
    View in: PubMed
    Score: 0.017
  17. Human B cell subsets. Adv Immunol. 2008; 98:151-224.
    View in: PubMed
    Score: 0.016
  18. Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem. 1996 Mar 15; 271(11):6342-8.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES